Real-world analysis of treatment patterns, effectiveness, and safety of daratumumab-based regimens in Chinese patients with newly diagnosed or relapsed/refractory multiple myeloma
This observational study provides real-world insights into treatment decisions for Chinese patients with MM. The effectiveness and safety results support the use of daratumumab-based treatment as a standard-of-care therapy in Chinese patients with newly diagnosed or relapsed/refractory MM. This study is ongoing, with continued collection of outcomes data during a longer follow-up.
Authors
- Wei Yang (ORCID: https://orcid.org/0000-0003-2138-5563)
- Kaiyang Ding (ORCID: https://orcid.org/0000-0002-5521-3519)
- Jin Lu (ORCID: https://orcid.org/0000-0001-5004-2741)
- Canchan Cui (ORCID: https://orcid.org/0009-0007-4679-7851)
- Jianmin Zhuo (ORCID: https://orcid.org/0009-0004-6575-6244)
- Hui Liu (ORCID: https://orcid.org/0000-0002-8166-0216)
- Yuping Zhong (ORCID: https://orcid.org/0000-0001-6277-1183)
- Ting Niu (ORCID: https://orcid.org/0000-0003-1580-1014)
- Luqun Wang
- Xi Chen (ORCID: https://orcid.org/0000-0002-7995-6202)
- Yanhui Li (ORCID: https://orcid.org/0000-0002-5700-3953)
- Yafei Wang (ORCID: https://orcid.org/0000-0002-8369-2836)
- Hong Liu (ORCID: https://orcid.org/0000-0002-2670-620X)
- Baijun Fang (ORCID: https://orcid.org/0000-0002-9087-8604)
- Kai Sun (ORCID: https://orcid.org/0000-0003-3392-363X)
- Wenbin Qian (ORCID: https://orcid.org/0000-0002-9817-6674)
- Yishen Yang
- Rong Fu
Institutions
- Qingdao University (CN)
- University of Science and Technology of China (CN)
- Anhui Medical University (CN)
- Nantong University (CN)
- Sichuan University (CN)
- Tianjin Medical University General Hospital (CN)
- Tianjin Medical University Cancer Institute and Hospital (CN)
- Affiliated Hospital of Nantong University (CN)
- West China Hospital of Sichuan University (CN)
- iQIYI (China) (CN)
- Beijing Hospital (CN)
- Qingdao Municipal Hospital (CN)
- Henan Provincial People's Hospital (CN)
- First Affiliated Hospital of Anhui Medical University (CN)
- Henan Cancer Hospital (CN)
- Second Affiliated Hospital of Zhejiang University (CN)
- Qilu Hospital of Shandong University (CN)
- China Medical University (CN)
Publication Details
- Journal
- BMC Cancer
- Published
- 2025-05-07
- DOI
- https://doi.org/10.1186/s12885-025-13925-3
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Johnson and Johnson